Disability improvement in relapsing-remitting multiple sclerosis patients receiving cladribine tablets, evaluated by expanded disability status scale

被引:0
|
作者
Sormani, M. P. [1 ,2 ]
Giovannoni, G. [3 ]
Signori, A. [1 ]
Alexandri, N. [4 ]
机构
[1] Univ Genoa, Genoa, Italy
[2] Osped Policlin San Martino, Genoa, Italy
[3] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England
[4] Merck KGaA, Darmstadt, Germany
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P0201
引用
收藏
页码:215 / 215
页数:1
相关论文
共 50 条
  • [1] Evaluation of Disability Improvement in Patients with Relapsing-Remitting Multiple Sclerosis Receiving Cladribine Tablets as Measured by the Expanded Disability Status Scale Score
    Sormani, Maria Pia
    Signori, Alessio
    Giovannoni, Gavin
    Alexandri, Nektaria
    NEUROLOGY, 2020, 94 (15)
  • [2] Prevalence of disability improvement in relapsing-remitting multiple sclerosis patients treated with cladribine tablets
    Signori, Alessio
    Ponzano, Marta
    Alexandri, Nektaria
    Giovannoni, Gavin
    Sormani, Maria Pia
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 (07) : 2144 - 2147
  • [3] Cladribine Tablets In Relapsing-Remitting Multiple Sclerosis
    Muir, Victoria J.
    Plosker, Greg L.
    CNS DRUGS, 2011, 25 (03) : 239 - 249
  • [4] Oxidative stress in relapsing-remitting multiple sclerosis patients in clinical remission: association with expanded disability status scale
    Oliveira, Sayonara Rangel
    Kallaur, Ana Paula
    Colado Simao, Andrea Name
    Kaimen-Maciel, Damacio Ramon
    Lopes, Josiane
    de Carvalho Jennings, Wildea Lice
    Panis, Carolina
    de Andrade, Renato Marques
    Pelegrino, Larissa Muliterno
    Vissoci Reiche, Edna Maria
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (12) : 1856 - 1856
  • [5] Correction to: Cladribine Tablets: In Relapsing-Remitting Multiple Sclerosis
    Victoria J. Muir
    Greg L. Plosker
    CNS Drugs, 2020, 34 : 447 - 447
  • [6] Cladribine tablets for the treatment of relapsing-remitting multiple sclerosis
    Comi, Giancarlo
    Hartung, Hans-Peter
    Kurukulasuriya, Nuwan C.
    Greenberg, Steven J.
    Scaramozza, Matthew
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (01) : 123 - 136
  • [7] Cognitive impairments in relapsing-remitting multiple sclerosis patients with low disability status
    Messinis, L.
    Anyfantis, E.
    Papathanasiou, T.
    Paschali, A.
    Papathanasopoulos, P.
    7TH INTERNATIONAL CONGRESS ON THE IMPROVEMENT OF THE QUALITY OF LIFE ON DEMENTIA, PARKINSON'S DISEASE, EPILEPSY, MS, MUSCULAR DISORDERS AND NEUROETHICS, 2009, : 36 - +
  • [8] PROGNOSIS OF DISABILITY IN RELAPSING-REMITTING MULTIPLE SCLEROSIS
    Somilo, O., V
    Kalbus, O., I
    Makarov, S. O.
    Sorokin, A. V.
    Shastun, N. P.
    WORLD OF MEDICINE AND BIOLOGY, 2023, 84 (02): : 147 - 152
  • [9] Disability trajectories in relapsing-remitting multiple sclerosis
    Uher, T.
    Horakova, D.
    Havrdova, E. Kubala
    Izquierdo, G.
    Eichau, S.
    Patti, F.
    Prat, A. P.
    Girard, M.
    Duquette, P.
    Grammond, P.
    Onofrj, M.
    Lugaresi, A. L.
    Bergamaschi, R.
    Ozakbas, S.
    Grand'Maison, F.
    Hupperts, R.
    Sola, P.
    Ferraro, D.
    Sa, M. J.
    Kalincik, T.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 813 - 814
  • [10] Serial analysis of magnetization-transfer histograms and expanded disability status scale scores in patients with relapsing-remitting multiple sclerosis
    Patel, UJ
    Grossman, RI
    Phillips, MD
    Udupa, JK
    McGowan, JC
    Miki, Y
    Wei, LG
    Polansky, M
    van Buchem, MA
    Kolson, D
    AMERICAN JOURNAL OF NEURORADIOLOGY, 1999, 20 (10) : 1946 - 1950